Astera Labs (NASDAQ:ALAB) CEO Sells 96,089 Shares of Stock

Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) CEO Jitendra Mohan sold 96,089 shares of the business’s stock in a transaction that occurred on Monday, November 16th. The stock was sold at an average price of $206.62, for a total value of $19,853,909.18. Following the transaction, the chief executive officer directly owned 1,170,576 shares in the company, valued at approximately $241,864,413.12. This trade represents a 7.59% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Astera Labs Trading Up 2.4%

NASDAQ:ALAB traded up $5.15 on Wednesday, hitting $216.75. The company’s stock had a trading volume of 4,544,353 shares, compared to its average volume of 5,136,489. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48. The firm has a market capitalization of $37.88 billion, a P/E ratio of 86.35 and a beta of 3.85. The stock has a fifty day moving average of $290.56 and a two-hundred day moving average of $257.51.

Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.19 by $0.13. The company had revenue of $584.90 million during the quarter, compared to the consensus estimate of $550.78 million. Astera Labs had a return on equity of 25.35% and a net margin of 29.64%. The firm’s revenue for the quarter was up 153.6% compared to the same quarter last year. During the same period in the previous year, the company posted $0.49 EPS. As a group, sell-side analysts anticipate that Astera Labs, Inc. will post 2.99 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on ALAB shares. Wall Street Zen raised shares of Astera Labs from a “hold” rating to a “buy” rating in a research report on Saturday, November 7th. Jefferies Financial Group increased their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Royal Bank Of Canada dropped their price objective on shares of Astera Labs from $500.00 to $400.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 4th. Roth Capital restated a “buy” rating and set a $450.00 target price on shares of Astera Labs in a research note on Wednesday, August 5th. Finally, Susquehanna reduced their target price on shares of Astera Labs from $310.00 to $258.00 and set a “neutral” rating for the company in a report on Wednesday, November 4th. Thirteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $320.85.

Get Our Latest Analysis on Astera Labs

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in Astera Labs during the second quarter worth approximately $6,609,581,000. Bank of America Corp DE bought a new stake in Astera Labs in the second quarter worth approximately $1,061,791,000. Atreides Management LP lifted its stake in Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after buying an additional 1,754,593 shares during the period. Amundi lifted its stake in Astera Labs by 77.9% in the first quarter. Amundi now owns 1,880,830 shares of the company’s stock valued at $206,139,000 after buying an additional 823,477 shares during the period. Finally, Deutsche Bank AG acquired a new position in Astera Labs in the second quarter valued at approximately $325,602,000. Institutional investors own 60.47% of the company’s stock.

More Astera Labs News

Here’s some of the latest news about ALAB:

  • Positive Sentiment: Astera expanded its partnership with Hyve Solutions, integrating its Orion Compute Board, Fabric Tray and Link Board into Hyve’s Apex platform. The pre-validated designs aim to speed AI-rack integration for enterprise data centers and accommodate different accelerators and CPUs, potentially broadening Astera’s opportunity as AI inference deployments grow. Article: How Does Astera Labs’ New AI Infrastructure Partnership Change Its Enterprise Opportunity?
  • Neutral Sentiment: General Counsel Philip Mazzara sold 4,380 shares, but the filing says the sale was to cover tax withholding on vested equity awards. He retained 92,190 shares, making this less indicative of a change in his view of the company. SEC Form 4 filing
  • Negative Sentiment: Reports describe continued share-price pressure, ETF net selling and analyst target resets despite strong growth. Comparisons with Amphenol also emphasize ALAB’s higher valuation, which may leave the stock vulnerable to further selling if expectations cool. Article: Why Is Astera Labs Stock Falling Again? Article: ETFs Are Net Sellers of Astera Labs

About Astera Labs

(Get Free Report)

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.

Featured Articles

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.